Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Important Note on the Evidence Base Important note on the evidence base: The published research on BPC-157 consists predominantly of animal-model studies (primarily rats) and in vitro cell-culture experiments
Anopheles midgut symbionts form dense and taxonomically diverse community that shapes vector fitness by modulating the characteristics of AMR and anti- Plasmodium immunity
Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events
Genistein-induced treatment of HeLa cells reduced promoter 5CpG methylation levels of various tumor suppressor genes involved in PI3K and MAPK signaling
US$ 28.96
US$ 24.88
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 24.72
US$ 25.87
US$ 21.25
US$ 24.84
